Dietary supplement use is often not reported to health care teams
the ONA take:
Research from Boston Medical Center found that some clinicians are not asking patients about their dietary supplement use, some patients do not disclose their use of them, and dietary supplement use is often not included in medical documentation.
This can challenge the effectiveness of prescription regimens and lead to serious repercussions for patients.
Researchers recently found an amphetamine-like stimulant in dietary supplements. As a result, stores such as the Vitamin Shoppe pulled as many as 25 supplements off their shelves because they contained the ingredient, which was linked to a woman’s stroke.
Another recent study found a number of supplements may even increase the risk of developing certain cancers.
Patients may not know that their health care team needs this information when planning their care or fear being judged for their use of the products.
The researchers conclude that clinicians need to be more conscious of and better educated on the importance of talking with patients of all ages and cultural backgrounds about dietary supplement use.
Some patients do not disclose their use of them, and dietary supplement use is often not included in medical documentation.
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses
- COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|